Ns Partners LTD Gilead Sciences, Inc. Transaction History

Ns Partners LTD

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2018 May 15, 2018	SELL	$72.84 - $88.8 $3.72 Million - $4.53 Million	-51,022 Closed	0 $0
Q4 2017 Feb 09, 2018	BUY	$71.15 - $83.52 $12,949 - $15,200	182 Added 0.36%	51,022 $3.66 Million
Q3 2017 Nov 14, 2017	BUY	$72.11 - $85.47 $1.24 Million - $1.47 Million	17,196 Added 51.11%	50,840 $4.12 Million
Q2 2017 Aug 14, 2017	BUY	N/A	33,644	33,644 $2.38 Million

1,885

8.71M

8.02M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $83.5B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of Ns Partners LTD, based on Form 13F filings with the SEC.

Stay updated on Ns Partners LTD with notifications on news.